Therapeutic vaccines now only reviewed by MRECs
Based on the Central Review of Medical Research Involving Human Subjects Decree (Besluit Centrale Beoordeling), the assesment task of the CCMO is limited to specific fields of study, including vaccine development. From 1 March 2022 only unauthorized prophylactic vaccines are reviewed by CCMO.
Therapeutic vaccines may now be reviewed by an accredited MREC, excepting therapeutic vaccines falling under another category that must be assessed by CCMO, such as ATMPs.